These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 203888)

  • 1. [Ristomycin, a new throbocyte aggregating agent. Comparative study of ristocetin and ristomycin (preliminary report)].
    Boda Z; Sztaricskai F; Rák K
    Orv Hetil; 1978 Jan; 119(5):259-61. PubMed ID: 203888
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ability of vancomycin-group antibiotics to induce or to inhibit thrombocyte agglutination].
    Rák K; Boda Z; Sztaricskai F
    Antibiotiki; 1980 Aug; 25(8):595-606. PubMed ID: 6250464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of platelet aggregation using the KZM-1-R meter (aggregation inducers: ADP, collagen, ristocetin, ristomycin, adrenaline. Therapy control by use of acetylsalicylic acid)].
    Stepanauskas M; Norden C; Söllner P; Heine H
    Z Med Lab Diagn; 1981; 22(3):148-54. PubMed ID: 6270924
    [No Abstract]   [Full Text] [Related]  

  • 4. Study of platelet agglutination induced by the antibiotics of the vancomycin group: ristocetin, ristomycin, actinoidin and vancomycin.
    Boda Z; Solum NO; Sztaricskai F; Rak K
    Thromb Haemost; 1979 Dec; 42(4):1164-80. PubMed ID: 232315
    [No Abstract]   [Full Text] [Related]  

  • 5. [IIB-type Willebrand disease (a case of increased ristomycin-induced aggregation)].
    Boda Z; Hársfalvi J; Rák K
    Orv Hetil; 1985 Aug; 126(32):1957-60. PubMed ID: 2993980
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of carbohydrate components of ristomycin A on platelet aggregation in human plasma].
    Trifonova ZhP; Sturman NV; Zheltova AO; Katrukha GS
    Antibiot Khimioter; 1989 Nov; 34(11):846-8. PubMed ID: 2633701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a new mode of defective ristocetin-induced platelet aggregation.
    Baugh RF; Hougie C
    J Lab Clin Med; 1981 Jun; 97(6):864-80. PubMed ID: 6971912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired ristocetin aggregation in myeloma due to binding of the aggregating agent by monoclonal protein--presentation of a case.
    László E; Péterfy M; Puskás E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(6):852-6. PubMed ID: 2453415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma components which interfere with ristocetin-induced platelet aggregation.
    Baugh RF; Brown JE; Hougie C
    Thromb Diath Haemorrh; 1975 Jun; 33(3):540-6. PubMed ID: 1080300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor.
    Allain JP; Cooper HA; Wagner RH; Brinkhous KM
    J Lab Clin Med; 1975 Feb; 85(2):318-28. PubMed ID: 234499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of sulfinpyrazone on enhanced platelet aggregation in vitro (author's transl)].
    Walter E; Weber E
    Arzneimittelforschung; 1978; 28(10):1778-81. PubMed ID: 582683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Destruction of the platelet aggregating activity of ristocetin A.
    Kuwahara S; Chambers WT
    Experientia; 1978 Apr; 34(4):532-4. PubMed ID: 565300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-glycosylthioureido aglyco-ristocetins without platelet aggregation activity.
    Sztaricskai F; Pintér G; Röth E; Herczegh P; Kardos S; Rozgonyi F; Boda Z
    J Antibiot (Tokyo); 2007 Aug; 60(8):529-33. PubMed ID: 17827665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibitory effect of kallikrein on ristocetin-induced platelet aggregation (author's transl)].
    Fukutake K; Ukita M; Kitamura T; Yamaguchi I
    Nihon Ketsueki Gakkai Zasshi; 1979 Jun; 42(3):549-50. PubMed ID: 495016
    [No Abstract]   [Full Text] [Related]  

  • 15. [Visual micromethod for determining thrombocyte aggregation activity in the presence of different aggregating agents].
    Shitikova AS
    Lab Delo; 1984; (4):215-20. PubMed ID: 6202940
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of platelet aggregation by moxalactam and free N-methylthiotetrazole.
    Ingalls CS; Somani P; Freimer EH
    Clin Ther; 1989; 11(5):640-51. PubMed ID: 2629724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Human factor VIII and platelet membrane glycoproteins implicated in ristocetin-induced aggregation (author's transl)].
    Niiya K; Koya H; Hayashi H; Nozaki H; Kitajima K
    Rinsho Ketsueki; 1978 Oct; 19(10):1322-31. PubMed ID: 570230
    [No Abstract]   [Full Text] [Related]  

  • 18. Preparation and platelet aggregating activity of 125I-labeled ristocetin.
    Baugh RF; Brown JE; Hougie C
    Anal Biochem; 1977 Mar; 78(1):39-46. PubMed ID: 848755
    [No Abstract]   [Full Text] [Related]  

  • 19. [von Willebrand's disease with an increased ristocetin-induced platelet aggregation and a qualitative abnormality of the factor VIII protein (author's transl)].
    Takahashi H; Oda E; Hattori A; Kobayashi I; Takahashi K; Sakuragawa N; Shibata A
    Rinsho Ketsueki; 1980 Apr; 21(4):544-54. PubMed ID: 6774131
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo effect of losartan on platelet aggregation in patients with hypertension.
    Akdemir R; Ozhan H; Yazici M; Gunduz H; Duran S; Gurel C; Ozdas S; Uyan C; Basar I; Ulutin T
    Heart Vessels; 2004 Jul; 19(4):167-71. PubMed ID: 15278389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.